- Screening assays
-The tools we offer to help you measure, and investigate, mitochondrial toxicity.
Every year, dozens of pharmaceutical compounds are withdrawn from the market due to adverse effects not discovered during the preclinical or clinical testing. Many of these adverse effects are subtle and do not lead to visible histopathology, but often lead to mitochondrial dysfunction. Therefore, screening for mitochondrial toxicity in the early development stages of a drug is essential.
This in-depth guide outlines the tools available to analyze mitochondrial toxicity.